---
name: arch saas-cells 2seat (SEC+SRE) panel response r1
description: 2026-05-15 — SEC+SRE-only per-point on Deep×2 SaaS-cells; 0 bidirectional CHALLENGE; ~12 SYNTHESIZE incl 4 new CRIT (observability/cardinality, GDPR-legal, Schrems-II locality, telemetry-ingestion); 12 Deep-only governance items; stop iterating
type: project
originSessionId: d7164c0c-ac60-44b9-b82d-a79cfa821216
---
2026-05-15. ~64th stacked-COI case overall, distinct from the SEC+SRE+FIN r1–r8 series — this one is **SEC + SRE only** (no FIN seat) per-point on Deep×2 saturation summary.

**Inputs**: Deep×2 (employee #4 5-vector COI + declined-to-re-list saturation note); Fresh-alt SRE (18 items); Fresh-alt SEC (19 items).

**Bidirectional CHALLENGE**: 0 (consistent with all prior cross-review rounds).

**Disposition tally**:
- AGREE: ~16 of 37 panel points
- SYNTHESIZE (additive/escalation): ~12
- CHALLENGE: 0

**Adoptions worth flagging**:
- New CRIT: SRE-14 (observability + per-cell metrics cardinality not budgeted), SEC-4 (GDPR/APPI/PIPA = legal prerequisite, not infra task), SEC-5 (CRDB active-active replicates everywhere → Schrems-II locality config regression risk), joint SRE-10 + SEC-13 (alert/SIEM telemetry 10–100×)
- Escalations: custom GLB → CRIT (security-critical adversarially-untested code in 100% request path, not just $)
- New HIGH: tenant rebalancing as SPOF (SRE-6), CRDB online schema ≠ PG (SRE-7), GitOps drift (SRE-8), IAM-per-cell (SEC-8), mTLS SAN over-scoping (SEC-6), mesh PERMISSIVE-default east-west exposure (SEC-9), NetworkPolicy enforcement of cell isolation (SEC-19), SOC2 audit-evidence scaling (SEC-16)
- Sharpenings: clock-skew/NTP-PTP discipline + rebalancing storms (SRE-2), CVE-accumulation in request path (SRE-17)

**Deep-only items the panel missed (~12, all governance/strategic)**:
F1–F6 falsification gates; saturation-as-evidence (organisational not technical); recusal-of-3; external IC chair (~$5–15K); Series-A opportunity cost; post-pain vs pre-pain cell-adoption framing (Stripe/Shopify/Discord); dual-stack-dual-region migration trap (D2); rollback-after-cutover data reconciliation (D3); off-ramp/reversibility planning; 6-month re-eval cadence; F6 board-minute test; CFO/lead-investor/departing-engineer as unexplored useful seats.

**Verdict**: defer + decompose + diagnose-first ~$30–60K + recuse-of-3 + external IC chair. Stable. 0/6 falsification gates met.

**Calibration**: do not run another role-lens panel pass on this case — saturated. Next useful seat = CFO runway math, board/lead-investor lens, or departing-engineer exit interview.
